C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes

Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
12/2002
12/19/2002	US20020192661 Method for the direct, exponential amplification and sequencing of DNA molecules and its application
12/19/2002	US20020192659 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020192640 Purified active HCV NS2/3 protease
12/19/2002	US20020192305 Inflammatory mediation obtained from atractylodes lancea
12/19/2002	US20020192218 Oncoprotein protein kinase
12/19/2002	US20020192209 Methods and compositions for inhibiting neoplastic cell growth
12/19/2002	US20020192204 15985, a novel human serine/threonine protein kinase family member and uses thereof
12/19/2002	US20020192200 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells
12/19/2002	US20020192160 Novel human tumor suppressor gene
12/19/2002	CA2465884A1 Transgenic plants synthesising high amylose starch
12/19/2002	CA2450320A1 Dna sequencing method
12/19/2002	CA2450319A1 Mutant rna polymerases
12/19/2002	CA2449920A1 Modifying nicotine and nitrosamine levels in tobacco
12/19/2002	CA2449602A1 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	CA2449598A1 Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid
12/18/2002	EP1267273A2 Interactive optical storage medium having preloaded font information, and apparatus and method for reproducing data from interactive optical storage medium
12/18/2002	EP1266968A2 Microorganism producing fructosyl transferase and method for producing fructooligosaccharides and neofructooligosaccharides using the same
12/18/2002	EP1266907A1 67108, a Human phospholipid transporter family member and uses therefor
12/18/2002	EP1266662A2 Synthetic peptide vaccines for dental caries
12/18/2002	EP1266224A1 Modulation of histone deacetylase
12/18/2002	EP1266036A1 Methods and compositions for identifying a protease
12/18/2002	EP1266035A1 Improved methods for generating catalytic proteins
12/18/2002	EP1266033A1 Method of reverse transcription using bacillus steraothermophilus or thermoactinomyces vulgaris dna polymerase
12/18/2002	EP1266026A1 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase beta/zeta
12/18/2002	EP1266024A1 High fidelity reverse transcriptases and uses thereof
12/18/2002	EP1266018A2 Production of secreted proteins by recombinant eukaryotic cells
12/18/2002	EP1266013A2 Heparinase iii and uses thereof
12/18/2002	EP1266012A2 Proteases
12/18/2002	EP1266010A2 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins
12/18/2002	EP1266006A2 Production of recombinant blood clotting factors in human cell lines
12/18/2002	EP1265996A2 Identification of modulators of the interferon gamma signaling pathway and their use in restenosis treatment
12/18/2002	EP1265995A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
12/18/2002	EP1265993A1 Recombinant adenylcyclase and use thereof for screening molecules with proteolytic activity
12/18/2002	EP1265992A2 Materials and methods relating to the degradation of cdc25a in response to dna damage
12/18/2002	EP1265991A2 Sphingomyelinase enzymes and uses relating thereto
12/18/2002	EP1265990A2 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
12/18/2002	EP1265930A1 Cyclodextrin dimers with spacers having peptide structures for encapsulation of pharmaceutically active substances with potential high side-effects
12/18/2002	EP1265910A2 Nucleic acids, proteins, and antibodies
12/18/2002	EP1265495A1 Method for preparing a roller dried protein preparation
12/18/2002	EP1265480A1 Chimeric animal model susceptible to human hepatitis c virus infection
12/18/2002	EP1265477A2 Transformed plant having heterologous glucan branching enzyme activity
12/18/2002	EP1030922A4 $i(dull1) CODING FOR A STARCH SYNTHASE AND USES THEREOF
12/18/2002	EP0885224B1 Process for preparing ganciclovir derivatives
12/18/2002	EP0811068B1 HUMAN DNase I VARIANTS
12/18/2002	EP0715523B1 Purine nucleoside phosphorylase gene therapy for human malignancy
12/18/2002	EP0555370B1 Methods and applications for efficient genetic suppressor elements
12/18/2002	EP0521996B1 Catalytic antibody components
12/18/2002	CN1386134A Process for producing gamma-glutamylcysteine
12/18/2002	CN1385532A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002	CN1385529A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002	CN1385520A Aspergillus niger strains and use thereof
12/18/2002	CN1385519A Li's Trichoderma strains and use thereof
12/18/2002	CN1385425A Different crystalyzed (-)-6-chloro-4-cyclopropyl ethinyl-4-trifluoride-1,4-dihydro-2H-3,1-benzoxazine-2-ketone
12/18/2002	CN1096500C Process for the preparation of pyruvic acid
12/18/2002	CN1096236C Beverage having antionxidant system and method for reducing oxygen in beverage by same
12/17/2002	US6495743 Plant xylanases
12/17/2002	US6495740 Manipulation of cellulose and/or β-1,4-Glucan
12/17/2002	US6495739 Plant phosphatidic acid phosphatases
12/17/2002	US6495738 Aspergillus; genetic engineering
12/17/2002	US6495737 Methods and compositions for improving salicylic acid-independent systemic acquired disease resistance in plants
12/17/2002	US6495736 Compositions and methods for increasing bone mineralization
12/17/2002	US6495673 Expression library produced by mutagenesis
12/17/2002	US6495659 Water solubility
12/17/2002	US6495526 Inhibitors of cell-cycle progression and uses related thereto
12/17/2002	US6495519 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
12/17/2002	US6495376 Phosphoserine and phosphothreonine binding modules. the ww-domain containing polypeptides of the invention can be used, for example, to regulate cell growth; to treat neurodegenerative diseases; to screen for substances that
12/17/2002	US6495359 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
12/17/2002	US6495357 Lipolytic enzymes
12/17/2002	US6495355 Luciferase genes of photinus pyralis used as luminescence reporter genes; amino acid substitutions from the wild-type luc560 form, conservative with respect to isoleucine at position 323 and to serine at position 324
12/17/2002	US6495354 Synthases
12/17/2002	US6495353 Identification of protein kinase proteins which are human orthologues of the drosophila wart gene (hwart); tumor suppressor genes
12/17/2002	US6495349 Chimeric gene constructs
12/17/2002	US6495348 Mitomycin biosynthetic gene cluster
12/17/2002	US6495322 Said protein induces apoptosis or is capable of generating or selecting an antibody to claimed amino acid sequence
12/17/2002	US6495317 DNA encodingmannose 6-phosphate reductase and recombinants produced therefrom
12/17/2002	US6495136 Proteases having modified amino acid sequences conjugated to addition moieties
12/17/2002	CA2064783C Cytoprotective fatty moiety compounds
12/17/2002	CA1341409C Cloning and expression of htlv-iii dna
12/13/2002	WO2001096575A1 Ceramide kinase and dna encoding the same
12/13/2002	CA2412876A1 Ceramide kinase and dna encoding the same
12/12/2002	WO2002099131A1 Transcription factor binding element
12/12/2002	WO2002099111A2 Anther-specific taa1 genes encoding fatty acyl co-a reductases, and uses thereof
12/12/2002	WO2002099110A1 Cell cycle regulatory factor
12/12/2002	WO2002099109A1 Novel polypeptide, dna encoding the polypeptide and use thereof
12/12/2002	WO2002099099A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
12/12/2002	WO2002099098A1 Method of preparation of stabilized thrombin-activatable fibrinolysis inhibitor (tafi) and methods of use thereof
12/12/2002	WO2002099097A1 Novel compounds for chemiluminescense procedures
12/12/2002	WO2002099096A1 Regulation of human serine/threonine protein kinase-like enzyme
12/12/2002	WO2002099095A2 Improved isoprenoid production
12/12/2002	WO2002099094A2 Human serine/threonine protein kinase-like enzyme
12/12/2002	WO2002099093A2 Provision of a putative human hydroxymethyl-glutaryl-coa lyase-like enzyme
12/12/2002	WO2002099092A2 Production of recombinant human lysosomal alpha-mannosidase
12/12/2002	WO2002099091A2 Endo-beta-1,4-glucanase from bacillus
12/12/2002	WO2002099090A1 Bcl-2 dnazymes
12/12/2002	WO2002099063A2 Alteration of embryo/endosperm size during seed development
12/12/2002	WO2002098918A2 Novel targets for a therapeutic intervention in ebv related diseases
12/12/2002	WO2002098894A1 Death associated kinase containing ankyrin repeats (dakar) and methods of use
12/12/2002	WO2002098885A1 Modified psma ligands and uses related thereto
12/12/2002	WO2002098824A2 Improvements in enzyme stability
12/12/2002	WO2002098458A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity

1 ... 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 ... 1416